Literature DB >> 24296541

Favorable outcome after a subdural hematoma treated with feiba in a 77-year-old patient treated by rivaroxaban.

Axel Maurice-Szamburski1, Thomas Graillon, Nicolas Bruder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24296541     DOI： 10.1097/ANA.0000000000000030

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN： 0898-4921            Impact factor:   3.956


× No keyword cloud information.
  9 in total

Review 1.  The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review.

Authors:  Maureane Hoffman; Joshua N Goldstein; Jerrold H Levy
Journal:  Int J Emerg Med       Date:  2018-12-03

Review 2.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 3.  Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management.

Authors:  Thomas J Cusack; J Ricardo Carhuapoma; Wendy C Ziai
Journal:  Curr Treat Options Neurol       Date:  2018-02-03       Impact factor: 3.598

4.  The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage.

Authors:  Jamil R Dibu; Jonathan M Weimer; Christine Ahrens; Edward Manno; Jennifer A Frontera
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

Review 5.  Current status of oral anticoagulant reversal strategies: a review.

Authors:  Aranyak Rawal; Devarshi Ardeshna; Sheharyar Minhas; Brandon Cave; Uzoma Ibeguogu; Rami Khouzam
Journal:  Ann Transl Med       Date:  2019-09

6.  The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor.

Authors:  Nina Haagenrud Schultz; Hoa Thi Tuyet Tran; Stine Bjørnsen; Carola Elisabeth Henriksson; Per Morten Sandset; Pål Andre Holme
Journal:  Thromb J       Date:  2017-02-20

7.  Rivaroxaban-Induced Nontraumatic Spinal Subdural Hematoma: An Uncommon Yet Life-Threatening Complication.

Authors:  Mazen Zaarour; Samer Hassan; Nishitha Thumallapally; Qun Dai
Journal:  Case Rep Hematol       Date:  2015-10-12

Review 8.  Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review.

Authors:  Carlos Galhardo; Luiz Henrique Ide Yamauchi; Hugo Dantas; João Carlos de Campos Guerra
Journal:  Braz J Anesthesiol       Date:  2021-04-19

9.  The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro.

Authors:  Nina H Schultz; Hoa T T Tran; Stine Bjørnsen; Carola E Henriksson; Per M Sandset; Pål A Holme
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.